The air dispersion of exhaled droplets from patients is currently considered a major route of coronavirus disease 2019 (COVID-19) transmission, the use of non-invasive ventilation (NIV) should be more cautiously employed during the COVID-19 pandemic. Recently, helmet ventilation has been identified as the optimal treatment for acute hypoxia respiratory failure caused by COVID-19 due to its ability to deliver NIV respiratory support with high tolerability, low air leakage, and improved seal integrity. In the present review, we provide an evidence-based overview of the use of helmet ventilation in children with respiratory failure.
All Keywords
【저자키워드】 Coronavirus disease 2019, Respiratory failure, pediatric, Continuous Positive Airway Pressure, non-invasive positive pressure ventilation, Non-invasive respiratory support, helmet ventilation, 【초록키워드】 COVID-19, Treatment, coronavirus disease, hypoxia, children, COVID-19 pandemic, Ventilation, Transmission, droplet, Patient, non-invasive ventilation, Respiratory Support, Tolerability, NIV, caused, 【제목키워드】 COVID-19, review, narrative,
【저자키워드】 Coronavirus disease 2019, Respiratory failure, pediatric, Continuous Positive Airway Pressure, non-invasive positive pressure ventilation, Non-invasive respiratory support, helmet ventilation, 【초록키워드】 COVID-19, Treatment, coronavirus disease, hypoxia, children, COVID-19 pandemic, Ventilation, Transmission, droplet, Patient, non-invasive ventilation, Respiratory Support, Tolerability, NIV, caused, 【제목키워드】 COVID-19, review, narrative,